Genomix Co., Ltd.
Records under this name other than patents Genomix Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Genomix Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,364,276 | Peptide for Inducing Regeneration of Tissue and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,550,165 | Peptide for Inducing Regeneration of Tissue and Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,623,078 | Novel Method for Treating Cardiac Infarction Using HMGB1 Fragment Formerly held In force · High confidence | In force | High confidence | |
| US 9,688,733 | Novel Method for Treating Spinal Cord Injury Using HMGB1 Fragment Formerly held In force · High confidence | In force | High confidence | |
| US 9,919,010 | Method for Collecting Functional Cells in Vivo with High Efficiency Formerly held Lapsed on the fee record Ended Mar 20, 2026 · High confidence | Lapsed on the fee record | Ended Mar 20, 2026 | High confidence |
| US 8,673,580 | Agent for Recruitment of Bone-Marrow-Derived Pluripotent Stem Cell Into Peripheral Circulation Formerly held Lapsed on the fee record Ended Mar 18, 2026 · High confidence | Lapsed on the fee record | Ended Mar 18, 2026 | High confidence |
| US 11,197,895 | Method for Collecting Functional Cells in Vivo with High Efficiency Formerly held Lapsed on the fee record Ended Dec 14, 2025 · Medium confidence | Lapsed on the fee record | Ended Dec 14, 2025 | Medium confidence |
| US 11,191,786 | Agents for Promoting Tissue Regeneration by Recruiting Bone Marrow Mesenchymal Stem Cells And/Or Pluripotent Stem Cells into Blood Formerly held Lapsed on the fee record Ended Dec 7, 2025 · High confidence | Lapsed on the fee record | Ended Dec 7, 2025 | High confidence |